---
category: news
title: "Poolbeg Pharma and CytoReason talk up unique AI opportunity to advance flu treatments"
excerpt: "Data is a critical component in AI systems that model disease and their potential treatments, Harel highlights in the video, and the Poolbeg tie-up is expected to provide unique sets of patient data, potentially allowing for new drug discovery. Skillington ..."
publishedDateTime: 2022-04-07T06:30:00Z
originalUrl: "https://www.proactiveinvestors.com/companies/news/979023/poolbeg-pharma-and-cytoreason-talk-up-unique-ai-opportunity-to-advance-flu-treatments-979023.html"
webUrl: "https://www.proactiveinvestors.com/companies/news/979023/poolbeg-pharma-and-cytoreason-talk-up-unique-ai-opportunity-to-advance-flu-treatments-979023.html"
ampWebUrl: "https://www.proactiveinvestors.com/companies/amp/news/979023"
cdnAmpWebUrl: "https://www-proactiveinvestors-com.cdn.ampproject.org/c/s/www.proactiveinvestors.com/companies/amp/news/979023"
type: article
quality: 30
heat: 30
published: false

provider:
  name: Proactiveinvestors
  domain: proactiveinvestors.com

topics:
  - AI

secured: "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;nLQ9OkVep9s2mKqGdYsNfw=="
---

